NORTRIPTYLINE (nortriptyline HCl)
DEPRESSION
WATSON LABS
Indication
Depression
Depression is a common and serious mood disorder that affects the central nervous system, influencing emotional regulation, cognition, and physical functioning across pediatric, adult, and geriatric populations. Read more about Depression
140 drugs 90 manufacturers
Drugs that treat it
Common Depression therapies.
PROTRIPTYLINE HCL
DEPRESSION
ROXANE LABS.
IMIPRAMINE HCL
DEPRESSION·+1
EXCELLIUM PHARM
NORTRIPTYLINE HCL
ANTIDEPRESSANTS·DEPRESSION
PHARMACEU ASSOC
TRIMIPRAMINE MALEATE
DEPRESSION
ACTAVIS PHARMA,
DESIPRAMINE HCL
DEPRESSION
ACTAVIS PHARMA,
AMOXAPINE
ANXIETY WITH DEPRESSION·+1
ACTAVIS PHARMA,
NORTRIPTYLINE HCL
ANTIDEPRESSANTS·DEPRESSION
TARO PHARM USA
PROTRIPTYLINE HCL
DEPRESSION
HI-TECH PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Depression preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDepression is a common and serious mood disorder that affects the central nervous system, influencing emotional regulation, cognition, and physical functioning across pediatric, adult, and geriatric populations.
It is clinically defined by persistent feelings of sadness, emptiness, or irritability, accompanied by anhedonia, fatigue, alterations in sleep or appetite, impaired concentration, feelings of worthlessness, and potentially recurrent thoughts of death or suicide.
Pathophysiologically, the condition is multifactorial, involving complex disruptions in monoaminergic and glutamatergic neurotransmission, neuroplasticity, neuroendocrine stress pathways such as the hypothalamic-pituitary-adrenal axis, and immune-mediated neuroinflammation.
- medlineplus.gov
Depression is a common and serious mood disorder that affects the central nervous system, influencing emotional regulation, cognition, and physical functioning across pediatric, adult, and geriatric populations
- adaa.org
Depression is a common and serious mood disorder that affects the central nervous system, influencing emotional regulation, cognition, and physical functioning across pediatric, adult, and geriatric populations
- nih.gov
It is clinically defined by persistent feelings of sadness, emptiness, or irritability, accompanied by anhedonia, fatigue, alterations in sleep or appetite, impaired concentration, feelings of worthlessness, and potentially recurrent thoughts of death or suicide
- nih.gov
It is clinically defined by persistent feelings of sadness, emptiness, or irritability, accompanied by anhedonia, fatigue, alterations in sleep or appetite, impaired concentration, feelings of worthlessness, and potentially recurrent thoughts of death or suicide
- mhsystem.org
It is clinically defined by persistent feelings of sadness, emptiness, or irritability, accompanied by anhedonia, fatigue, alterations in sleep or appetite, impaired concentration, feelings of worthlessness, and potentially recurrent thoughts of death or suicide
- nih.gov
Pathophysiologically, the condition is multifactorial, involving complex disruptions in monoaminergic and glutamatergic neurotransmission, neuroplasticity, neuroendocrine stress pathways such as the hypothalamic-pituitary-adrenal axis, and immune-mediated neuroinflammation
Personalize your experience
Follow Depression and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.